{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:23:52Z","timestamp":1792790632305,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.autrev.2022.103219","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T03:00:50Z","timestamp":1666407650000},"page":"103219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":176,"title":["Eosinophilic granulomatosis with polyangiitis: A review"],"prefix":"10.1016","volume":"22","author":[{"given":"JPE","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103219_bb0005","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez570","article-title":"Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management","volume":"59","author":"Trivioli","year":"2020","journal-title":"Rheumatology"},{"issue":"549","key":"10.1016\/j.autrev.2022.103219_bb0010","first-page":"1","article-title":"Eosinophilic granulomatosis with polyangiitis: an overview","volume":"5","author":"Gioffredi","year":"2014","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.autrev.2022.103219_bb0015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.alit.2019.06.004","article-title":"Update on eosinophilic granulomatosis with polyangiitis","volume":"68","author":"Furuta","year":"2019","journal-title":"Allergol. Int."},{"issue":"2","key":"10.1016\/j.autrev.2022.103219_bb0020","first-page":"277","article-title":"Allergic granulomatosis, allergic angiitis, and periarteritis","volume":"27","author":"Churg","year":"1951","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.autrev.2022.103219_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.autrev.2022.103219_bb0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0","article-title":"Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom","volume":"43","author":"Watts","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103219_bb0035","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) straight to the point of care","author":"Keogh","year":"2018","journal-title":"BMJ Best Pract."},{"issue":"1","key":"10.1016\/j.autrev.2022.103219_bb0040","first-page":"1","article-title":"Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Straus)","volume":"00","author":"Papo","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103219_bb0045","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sabl\u00e9-Fourtassou","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.autrev.2022.103219_bb0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103219_bb0055","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.autrev.2022.103219_bb0060","doi-asserted-by":"crossref","DOI":"10.1148\/rg.273065051","article-title":"Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview","volume":"27","author":"Jeong","year":"2007","journal-title":"Radiographics."},{"issue":"3","key":"10.1016\/j.autrev.2022.103219_bb0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"529","key":"10.1016\/j.autrev.2022.103219_bb0070","first-page":"1","article-title":"Eosinophilia and kidney disease: more than just an incidental finding? iJ","volume":"7","author":"Gauckler","year":"2018","journal-title":"Clin. Med."},{"key":"10.1016\/j.autrev.2022.103219_bb0075","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/rheumatology\/kes171","article-title":"Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients","volume":"51","author":"Jakiela","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103219_bb0080","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autrev.2022.103219_bb0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0","article-title":"Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome","volume":"44","author":"Kiene","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.autrev.2022.103219_bb0090","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/08916930902832348","article-title":"Pathogenesis of Churg-Strauss syndrome: recent insights","volume":"42","author":"Zwerina","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2022.103219_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1196\/annals.1361.053","article-title":"Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome","volume":"1051","author":"Hellmich","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.autrev.2022.103219_bb0100","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/rheumatology\/kev242","article-title":"First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis","volume":"54","author":"Emmi","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103219_bb0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/all.12088","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss): state of the art. Allergy: European","volume":"68","author":"Vaglio","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autrev.2022.103219_bb0110","first-page":"S23","article-title":"Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome","volume":"29","author":"Jakiela","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.autrev.2022.103219_bb0115","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaci.2008.05.040","article-title":"Differences in regulatory T cells between Churg\u2013Strauss syndrome and chronic eosinophilic pneumonia with asthma","volume":"122","author":"Tsurikisawa","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autrev.2022.103219_bb0120","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/rheumatology\/ken033","article-title":"Eotaxin-3 is involved in Churg-Strauss syndrome\u2013a serum marker closely correlating with disease activity","volume":"47","author":"Polzer","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103219_bb0125","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1073\/pnas.76.3.1443","article-title":"Neurotoxicity of human eosinophils","volume":"76","author":"Durack","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8534","key":"10.1016\/j.autrev.2022.103219_bb0130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(87)90412-0","article-title":"Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease","volume":"1","author":"Tai","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2022.103219_bb0135","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1182\/blood-2010-02-267542","article-title":"Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg\u2013Strauss syndrome","volume":"116","author":"Terrier","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2022.103219_bb0140","article-title":"Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis","volume":"5","author":"Teixeira","year":"2019","journal-title":"Rheumat. Musculoskeletal Dis. Open"},{"key":"10.1016\/j.autrev.2022.103219_bb0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/ard.2011.155382","article-title":"IgG4 immune response in Churg\u2013Strauss syndrome","volume":"71","author":"Vaglio","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103219_bb0150","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/art.10830","article-title":"Are environmental factors important in primary systemic vasculitis? A case-control study","volume":"48","author":"Lane","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103219_bb0155","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mai.2002.120854","article-title":"Asthma therapies and Churg-Strauss syndrome","volume":"109","author":"Lilly","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autrev.2022.103219_bb0160","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/pds.1353","article-title":"Asthma drug use and the development of Churg-Strauss syndrome (CSS)","volume":"16","author":"Harrold","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.autrev.2022.103219_bb0165","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/thx.2007.087825","article-title":"The leucotriene receptor antagonist montelukast and the risk of Churg- Strauss syndrome: a case-crossover study","volume":"63","author":"Hauser","year":"2008","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.autrev.2022.103219_bb0170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000500544","article-title":"Anti-neutrophil cytoplasmic antibodies positivity and anti-leukotrienes in eosinophilic granulomatosis with polyangiitis: a retrospective monocentric study on 134 Italian patients","volume":"180","author":"Schroeder","year":"2019","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.autrev.2022.103219_bb0175","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.22834","article-title":"HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome","volume":"56","author":"Vaglio","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103219_bb0180","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/art.23496","article-title":"Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg- Strauss syndrome, but not with Wegener\u2019s granulomatosis","volume":"58","author":"Wieczorek","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103219_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/j.1398-9995.2007.01486.x","article-title":"The common allergens in the Churg\u2013Strauss syndrome","volume":"62","author":"Bottero","year":"2007","journal-title":"Allergy: Eur. J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autrev.2022.103219_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/00016480500437435","article-title":"Ear, nose and throat manifestations of Churg-Strauss syndrome","volume":"126","author":"Bacciu","year":"2006","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.autrev.2022.103219_bb0195","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MLG.0b013e318159889d","article-title":"Nasal polyposis in Churg-Strauss syndrome","volume":"118","author":"Bacciu","year":"2008","journal-title":"Laryngoscope"},{"issue":"12","key":"10.1016\/j.autrev.2022.103219_bb0200","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s00330-007-0700-4","article-title":"Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings","volume":"17","author":"Kim","year":"2007","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.autrev.2022.103219_bb0205","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Straus)","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.autrev.2022.103219_bb0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2022.103219_bb0215","first-page":"keab027","article-title":"Heart disease in eosinophilic granulomatosis with polyangiitis (EPGA) patients: a screening approach proposal","author":"Garcia-Vives","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103219_bb0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3899\/jrheum.161436","article-title":"Long term prognosis of 121 patients with eosinophilic granulomatosis with polyangiitis in Japan","volume":"44","author":"Tsurikisawa","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.autrev.2022.103219_bb0225","first-page":"126","article-title":"Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series","volume":"33","author":"Monti","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.autrev.2022.103219_bb0230","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","article-title":"A vasculitis Centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients","volume":"72","author":"Moosig","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103219_bb0235","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0b013e3181af35a5","article-title":"Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis","volume":"88","author":"Neumann","year":"2009","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2022.103219_bb0240","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1253\/circj.CJ-10-0772","article-title":"Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission","volume":"75","author":"Szczeklik","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.autrev.2022.103219_bb0245","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10554-012-0158-6","article-title":"Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener\u2019s) in patients with normal electrocardiograms and transthoracic echocardiography","volume":"29","author":"Miszalski-Jamka","year":"2013","journal-title":"Int. J. Card. Imaging"},{"key":"10.1016\/j.autrev.2022.103219_bb0250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","volume":"84","author":"Pagnoux","year":"2005","journal-title":"Medicine"},{"issue":"1071932","key":"10.1016\/j.autrev.2022.103219_bb0255","first-page":"1","article-title":"Multiple ulcerations and perforation in the small intestine after steroid treatment in eosinophilic granulomatosis with polyangiitis: a case report and literature review","volume":"47","author":"Ito","year":"2020","journal-title":"Cardiovasc. Pathol."},{"issue":"S01","key":"10.1016\/j.autrev.2022.103219_bb0260","first-page":"492","article-title":"Eosinophilic granulomatosis with polyangiitis involving the small intestine: radiographic and endoscopic findings","volume":"47","author":"Kawasaki","year":"2015","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.autrev.2022.103219_bb0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3988\/jcn.2017.13.1.77","article-title":"Clinical characteristics and treatment response of peripheral neuropathy in the presence of eosinophilic granulomatosis with Polyangiitis (Churg-Strauss syndrome): experience at a single tertiary center","volume":"13","author":"Cho","year":"2017","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.autrev.2022.103219_bb0270","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/jnnp.2006.111013","article-title":"Peripheral neuropathy in Wegener\u2019s granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis","volume":"78","author":"Cattaneo","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.autrev.2022.103219_bb0275","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/brain\/122.3.427","article-title":"Clinicopathological features of Churg-Strauss syndrome-associated neuropathy","volume":"122","author":"Hattori","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2022.103219_bb0280","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/rheumatology\/keaa416","article-title":"Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases","volume":"60","author":"Durel","year":"2021","journal-title":"Rheumatology"},{"issue":"5 Suppl 1","key":"10.1016\/j.autrev.2022.103219_bb0285","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1590\/abd1806-4841.20175522","article-title":"Cutaneous manifestations of Churg-Strauss syndrome: key to diagnosis","volume":"92","author":"Marques","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.autrev.2022.103219_bb0290","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1196\/annals.1381.041","article-title":"Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome","volume":"1107","author":"Guilpain","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.autrev.2022.103219_bb0295","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/rheumatology\/keq445","article-title":"Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study","volume":"50","author":"Zwerina","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103219_bb0300","first-page":"44","article-title":"Pathogenesis and biomarkers in ANCA-associated vasculitis","volume":"5","author":"Almeida","year":"2021","journal-title":"Vessel Plus"},{"key":"10.1016\/j.autrev.2022.103219_bb0305","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/322707","article-title":"Diagnosis of Strongyloides stercoralis infection","volume":"33","author":"Siddiqui","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.autrev.2022.103219_bb0310","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(88)91486-9","article-title":"The expanded spectrum of toxocaral disease","volume":"1","author":"Taylor","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2022.103219_bb0315","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","article-title":"Refining the definition of hypereosinophilic syndrome","volume":"126","author":"Simon","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autrev.2022.103219_bb0320","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ajh.23293","article-title":"World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management","volume":"87","author":"Gotlib","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.autrev.2022.103219_bb0325","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2009.021675","article-title":"Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1","volume":"95","author":"Bain","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2022.103219_bb0330","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1398-9995.2012.02873.x","article-title":"Serum biomarkers are similar in Churg\u2013Strauss syndrome and hypereosinophilic syndrome","volume":"67","author":"Khoury","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.autrev.2022.103219_bb0335","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autrev.2022.103219_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autrev.2022.103219_bb0345","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/rheumatology\/kev242","article-title":"First report of FIP1L1-PDGFRalpha-positive eosinophilic granulomatosis with polyangiitis","volume":"54","author":"Emmi","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103219_bb0350","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2022.103219_bb0355","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-1-11","article-title":"Idiopathic chronic eosinophilic pneumonia","volume":"1","author":"Marchand","year":"2006","journal-title":"Orphanet J. Rare. Dis."},{"issue":"9","key":"10.1016\/j.autrev.2022.103219_bb0360","first-page":"1006","article-title":"Churg\u2013Strauss syndrome","volume":"76","author":"Vaglio","year":"2009","journal-title":"Renal Consult."},{"key":"10.1016\/j.autrev.2022.103219_bb0365","doi-asserted-by":"crossref","first-page":"iii123","DOI":"10.1093\/rheumatology\/kez667","article-title":"IgG4-related disease: a clinical perspective","volume":"59","author":"Maritati","year":"2020","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.autrev.2022.103219_bb0370","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French vasculitis study group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2022.103219_bb0375","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.22679","article-title":"Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients","volume":"57","author":"Cohen","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103219_bb0380","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/art.23198","article-title":"Treatment of Churg\u2013Strauss syndrome without poor-prognosis factors: a multi center, prospective, randomized, open-label study of seventy-two patients","volume":"58","author":"Ribi","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103219_bb0385","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103219_bb0390","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) consensus task force recommendations for evaluation and management","volume":"26","author":"Groh","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.autrev.2022.103219_bb0395","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/art.40205","article-title":"Adding azathioprine to remission-induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (Churg- Strauss), microscopic polyangiitis, or polyarteritis nodosa without poor prognosis factors: a randomized, controlled trial","volume":"69","author":"Puechal","year":"2017","journal-title":"Arthritis Rheum."},{"issue":"26","key":"10.1016\/j.autrev.2022.103219_bb0400","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autrev.2022.103219_bb0405","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.autrev.2022.103219_bb0410","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s10067-017-3944-7","article-title":"Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis","volume":"37","author":"La-Crette","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.autrev.2022.103219_bb0415","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.autrev.2022.103219_bb0420","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term follow up of polyarteritis nodosa, microscopic polyangiitis, and Churg\u2013Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.autrev.2022.103219_bb0425","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.21263","article-title":"Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus","volume":"52","author":"Somers","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103219_bb0430","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.39011","article-title":"Treatment of systemic necrotizing vasculitides in patients aged sixty five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy","volume":"67","author":"Pagnoux","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103219_bb0435","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","article-title":"Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis","volume":"42","author":"Klemmer","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.autrev.2022.103219_bb0440","first-page":"24","article-title":"Interferon-alpha for maintenance of remission in Churg- Strauss syndrome: a long-term observational study","volume":"28","author":"Metzler","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.autrev.2022.103219_bb0445","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.autrev.2022.103219_bb0450","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autrev.2022.103219_bb0455","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar4313","article-title":"Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)","volume":"15","author":"Thiel","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.autrev.2022.103219_bb0460","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/ndt\/gfq852","article-title":"Rituximab for the treatment of Churg- Strauss syndrome with renal involvement","volume":"26","author":"Cartin-Ceba","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.autrev.2022.103219_bb0465","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/annrheumdis-2014-206095","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"75","author":"Mohammad","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103219_bb0470","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/annrheumdis-2017-211897","article-title":"Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis","volume":"77","author":"Emmi","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103219_bb0475","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.autrev.2022.103219_bb0480","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.autrev.2022.103219_bb0485","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jaci.2006.02.028","article-title":"Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma","volume":"117","author":"Noga","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autrev.2022.103219_bb0490","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/art.39663","article-title":"Anti-IgE monoclonal antibody (omalizumab) in refractory and relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss): data on seventeen patients","volume":"68","author":"Jachiet","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2022.103219_bb0495","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40413-018-0217-0","article-title":"Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases","volume":"11","author":"Celebi Sozener","year":"2018","journal-title":"World Allergy Org. J."},{"issue":"6","key":"10.1016\/j.autrev.2022.103219_bb0500","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.jaci.2018.11.041","article-title":"Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis","volume":"143","author":"Steinfeld","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autrev.2022.103219_bb0505","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","volume":"125","author":"Kim","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autrev.2022.103219_bb0510","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/annrheumdis-2020-eular.5544","article-title":"OP0148\u00a0Mepolizumab for eosinophilic granulomatosis with Polyangiitis (EGPA): a retrospective real-world European study on 142 patients","volume":"79","author":"Bettiol","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2022.103219_bb0515","author":"ClinicalTrials.gov"},{"issue":"1","key":"10.1016\/j.autrev.2022.103219_bb0520","first-page":"00311","article-title":"Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis","volume":"6","author":"Kent","year":"2020","journal-title":"Eur. Respiratory Soc. J. Open Res."},{"key":"10.1016\/j.autrev.2022.103219_bb0525","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/rheumatology\/kez139","article-title":"Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial","volume":"58","author":"Pu\u00e9chal","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2022.103219_bb0530","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2013.03.003","article-title":"Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials","volume":"43","author":"Samson","year":"2013","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.autrev.2022.103219_bb0535","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr2.11263","article-title":"Vasculitis clinical research consortium. clinical manifestations and long-term outcomes of eosinophilic granulomatosis with polyangiitis in North America","volume":"3","author":"Doubelt","year":"2021","journal-title":"ACR Open Rheumatol."},{"issue":"9","key":"10.1016\/j.autrev.2022.103219_bb0540","first-page":"1249","article-title":"Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States","volume":"27","author":"Bell","year":"2021","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"8","key":"10.1016\/j.autrev.2022.103219_bb0545","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006083","article-title":"Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity","volume":"96","author":"Solans-Laqu\u00e9","year":"2017","journal-title":"Medicine (Baltimore)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:27:41Z","timestamp":1761600461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222001896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1568997222001896"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103219","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilic granulomatosis with polyangiitis: A review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103219"}}